US Stock MarketDetailed Quotes

60 Degrees Pharmaceuticals (SXTP)

Watchlist
  • 1.630
  • -0.080-4.68%
Close Apr 24 16:00 ET
  • 1.610
  • -0.020-1.23%
Post 20:01 ET
4.30MMarket Cap-0.14P/E (TTM)

60 Degrees Pharmaceuticals (SXTP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-21.26%-6.85M
-3.31%-1.69M
-25.45%-2.11M
-22.04%-1.45M
-40.07%-1.6M
-24.33%-5.65M
-2,473.06%-1.64M
55.20%-1.68M
-279.03%-1.19M
-176.35%-1.14M
Net income from continuing operations
7.38%-7.37M
29.77%-1.44M
-7.25%-2.32M
58.44%-1.73M
-538.64%-1.88M
-108.60%-7.96M
-0.13%-2.05M
-151.77%-2.16M
-24.84%-4.17M
116.48%427.99K
Operating gains losses
84.03%-266.09K
-2,575.59%-422.53K
-62.79%21.1K
12,656.31%140.45K
99.71%-5.11K
-199.85%-1.67M
-87.13%17.07K
-81.04%56.71K
-99.72%1.1K
-306.01%-1.74M
Depreciation and amortization
30.01%82.87K
47.78%23.57K
55.74%22.83K
78.76%19.68K
-24.10%16.8K
-36.49%63.75K
-31.98%15.95K
-42.36%14.66K
-55.95%11.01K
-16.50%22.13K
Change In working capital
-102.85%-5.5K
-87.84%26.61K
39.52%-159.65K
-79.18%46.06K
392.42%81.48K
-52.46%192.72K
-83.27%218.93K
89.57%-263.99K
-75.07%221.24K
-97.76%16.55K
-Change in receivables
91.04%-22.9K
200.90%164.39K
-1,280.60%-379K
873.35%193.21K
98.24%-1.5K
-37.79%-255.42K
-74.58%-162.93K
-118.93%-27.45K
146.58%19.85K
-130.11%-84.89K
-Change in inventory
-2,090.33%-465.84K
-1,576.65%-136.92K
206.61%27.74K
-379.82%-26.18K
-1,173.25%-330.47K
-89.00%23.41K
-93.92%9.27K
-143.77%-26.02K
-91.40%9.36K
128.49%30.79K
-Change in prepaid assets
50.57%-19.49K
-149.49%-29.86K
0.29%-253.54K
42.68%132.22K
112.95%131.69K
92.45%-39.42K
-93.91%60.33K
82.79%-254.27K
273.12%92.67K
243.18%61.84K
-Change in payables and accrued expense
5.21%502.72K
-90.71%29K
917.66%445.15K
-354.81%-253.19K
1,154.94%281.76K
-54.52%477.81K
14.69%312.25K
104.62%43.74K
-88.80%99.36K
-97.32%22.45K
-Change in other current liabilities
--0
--0
--0
--0
--0
72.85%-13.65K
--0
--0
--0
-11.46%-13.65K
Cash from discontinued investing activities
Operating cash flow
-21.26%-6.85M
-3.31%-1.69M
-25.45%-2.11M
-22.04%-1.45M
-40.07%-1.6M
-24.33%-5.65M
-2,473.06%-1.64M
55.20%-1.68M
-279.03%-1.19M
-176.35%-1.14M
Investing cash flow
Cash flow from continuing investing activities
113.49%254.92K
-65,220.83%-1.37M
98.54%-25.49K
60.41%-51.68K
17,447.85%1.7M
-1,530.12%-1.89M
96.85%-2.1K
-6,158.80%-1.75M
-620.25%-130.56K
-198.12%-9.81K
Capital expenditure reported
-6.86%-55.53K
-1,552.29%-34.67K
36.47%-13.7K
84.18%-4.36K
-286.23%-2.8K
-29.98%-51.97K
80.51%-2.1K
-56.30%-21.57K
-127.36%-27.57K
77.95%-726
Net PPE purchase and sale
-34.80%-139.88K
---79.88K
27.40%-10K
47.42%-47.32K
---2.68K
-80.09%-103.77K
--0
-655.51%-13.77K
---90K
--0
Net intangibles purchase and sale
10.66%-22.67K
---20.89K
45.89%-1.79K
--0
--0
-38.78%-25.37K
--0
73.14%-3.3K
-116.45%-12.99K
---9.09K
Net investment purchase and sale
127.69%473K
---1.24M
--0
--0
--1.71M
---1.71M
--0
---1.71M
--0
--0
Cash from discontinued investing activities
Investing cash flow
113.49%254.92K
-65,220.83%-1.37M
98.54%-25.49K
60.41%-51.68K
17,447.85%1.7M
-1,530.12%-1.89M
96.85%-2.1K
-6,158.80%-1.75M
-620.25%-130.56K
-198.12%-9.81K
Financing cash flow
Cash flow from continuing financing activities
-8.73%6.44M
47,034.02%458.61K
-16.85%4.28M
0
-10.84%1.7M
8.94%7.05M
973
-13.75%5.15M
-100.27%-865
943.54%1.9M
Net issuance payments of debt
----
----
----
----
----
--0
--0
--0
----
----
Net common stock issuance
-8.37%6.45M
--458.61K
-16.78%4.28M
--0
-9.76%1.71M
11.72%7.04M
--0
-20.30%5.14M
--0
--1.9M
Proceeds from stock option exercised by employees
-74.42%2.8K
--0
--878
--0
-61.44%1.93K
-99.03%10.96K
--973
--0
--5K
--5K
Net other financing activities
---18K
--0
--0
--0
-10.99%-18K
----
----
-2,382.38%-96.22K
98.22%-5.86K
-108.89%-16.22K
Cash from discontinued financing activities
Financing cash flow
-8.73%6.44M
47,034.02%458.61K
-16.85%4.28M
--0
-10.84%1.7M
8.94%7.05M
--973
-13.75%5.15M
-100.27%-865
943.54%1.9M
Net cash flow
Beginning cash position
-22.55%1.66M
24.69%4.12M
24.76%1.97M
19.24%3.45M
-22.55%1.66M
708.90%2.14M
48.78%3.3M
8,167.45%1.58M
9,551.25%2.89M
708.90%2.14M
Current changes in cash
67.66%-156.42K
-58.86%-2.6M
24.69%2.15M
-13.81%-1.5M
139.30%1.8M
-126.64%-483.63K
-1,158.81%-1.64M
-21.36%1.72M
-12,409.58%-1.32M
422.39%753.04K
Effect of exchange rate changes
1,328.26%7.13K
27.70%-1.44K
-30.82%1.23K
1,021.07%17.24K
-1,101.94%-9.9K
-99.19%499
-103.68%-1.99K
-80.97%1.78K
511.23%1.54K
36.12%-824
End cash Position
-9.00%1.51M
-9.00%1.51M
24.69%4.12M
24.76%1.97M
19.24%3.45M
-22.55%1.66M
-22.55%1.66M
48.78%3.3M
8,167.45%1.58M
9,551.25%2.89M
Free cash flow
-21.24%-7.07M
-11.44%-1.83M
-24.11%-2.13M
-13.88%-1.5M
-39.35%-1.6M
-25.12%-5.83M
-1,159.55%-1.64M
54.51%-1.72M
-297.68%-1.32M
-176.52%-1.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -21.26%-6.85M-3.31%-1.69M-25.45%-2.11M-22.04%-1.45M-40.07%-1.6M-24.33%-5.65M-2,473.06%-1.64M55.20%-1.68M-279.03%-1.19M-176.35%-1.14M
Net income from continuing operations 7.38%-7.37M29.77%-1.44M-7.25%-2.32M58.44%-1.73M-538.64%-1.88M-108.60%-7.96M-0.13%-2.05M-151.77%-2.16M-24.84%-4.17M116.48%427.99K
Operating gains losses 84.03%-266.09K-2,575.59%-422.53K-62.79%21.1K12,656.31%140.45K99.71%-5.11K-199.85%-1.67M-87.13%17.07K-81.04%56.71K-99.72%1.1K-306.01%-1.74M
Depreciation and amortization 30.01%82.87K47.78%23.57K55.74%22.83K78.76%19.68K-24.10%16.8K-36.49%63.75K-31.98%15.95K-42.36%14.66K-55.95%11.01K-16.50%22.13K
Change In working capital -102.85%-5.5K-87.84%26.61K39.52%-159.65K-79.18%46.06K392.42%81.48K-52.46%192.72K-83.27%218.93K89.57%-263.99K-75.07%221.24K-97.76%16.55K
-Change in receivables 91.04%-22.9K200.90%164.39K-1,280.60%-379K873.35%193.21K98.24%-1.5K-37.79%-255.42K-74.58%-162.93K-118.93%-27.45K146.58%19.85K-130.11%-84.89K
-Change in inventory -2,090.33%-465.84K-1,576.65%-136.92K206.61%27.74K-379.82%-26.18K-1,173.25%-330.47K-89.00%23.41K-93.92%9.27K-143.77%-26.02K-91.40%9.36K128.49%30.79K
-Change in prepaid assets 50.57%-19.49K-149.49%-29.86K0.29%-253.54K42.68%132.22K112.95%131.69K92.45%-39.42K-93.91%60.33K82.79%-254.27K273.12%92.67K243.18%61.84K
-Change in payables and accrued expense 5.21%502.72K-90.71%29K917.66%445.15K-354.81%-253.19K1,154.94%281.76K-54.52%477.81K14.69%312.25K104.62%43.74K-88.80%99.36K-97.32%22.45K
-Change in other current liabilities --0--0--0--0--072.85%-13.65K--0--0--0-11.46%-13.65K
Cash from discontinued investing activities
Operating cash flow -21.26%-6.85M-3.31%-1.69M-25.45%-2.11M-22.04%-1.45M-40.07%-1.6M-24.33%-5.65M-2,473.06%-1.64M55.20%-1.68M-279.03%-1.19M-176.35%-1.14M
Investing cash flow
Cash flow from continuing investing activities 113.49%254.92K-65,220.83%-1.37M98.54%-25.49K60.41%-51.68K17,447.85%1.7M-1,530.12%-1.89M96.85%-2.1K-6,158.80%-1.75M-620.25%-130.56K-198.12%-9.81K
Capital expenditure reported -6.86%-55.53K-1,552.29%-34.67K36.47%-13.7K84.18%-4.36K-286.23%-2.8K-29.98%-51.97K80.51%-2.1K-56.30%-21.57K-127.36%-27.57K77.95%-726
Net PPE purchase and sale -34.80%-139.88K---79.88K27.40%-10K47.42%-47.32K---2.68K-80.09%-103.77K--0-655.51%-13.77K---90K--0
Net intangibles purchase and sale 10.66%-22.67K---20.89K45.89%-1.79K--0--0-38.78%-25.37K--073.14%-3.3K-116.45%-12.99K---9.09K
Net investment purchase and sale 127.69%473K---1.24M--0--0--1.71M---1.71M--0---1.71M--0--0
Cash from discontinued investing activities
Investing cash flow 113.49%254.92K-65,220.83%-1.37M98.54%-25.49K60.41%-51.68K17,447.85%1.7M-1,530.12%-1.89M96.85%-2.1K-6,158.80%-1.75M-620.25%-130.56K-198.12%-9.81K
Financing cash flow
Cash flow from continuing financing activities -8.73%6.44M47,034.02%458.61K-16.85%4.28M0-10.84%1.7M8.94%7.05M973-13.75%5.15M-100.27%-865943.54%1.9M
Net issuance payments of debt ----------------------0--0--0--------
Net common stock issuance -8.37%6.45M--458.61K-16.78%4.28M--0-9.76%1.71M11.72%7.04M--0-20.30%5.14M--0--1.9M
Proceeds from stock option exercised by employees -74.42%2.8K--0--878--0-61.44%1.93K-99.03%10.96K--973--0--5K--5K
Net other financing activities ---18K--0--0--0-10.99%-18K---------2,382.38%-96.22K98.22%-5.86K-108.89%-16.22K
Cash from discontinued financing activities
Financing cash flow -8.73%6.44M47,034.02%458.61K-16.85%4.28M--0-10.84%1.7M8.94%7.05M--973-13.75%5.15M-100.27%-865943.54%1.9M
Net cash flow
Beginning cash position -22.55%1.66M24.69%4.12M24.76%1.97M19.24%3.45M-22.55%1.66M708.90%2.14M48.78%3.3M8,167.45%1.58M9,551.25%2.89M708.90%2.14M
Current changes in cash 67.66%-156.42K-58.86%-2.6M24.69%2.15M-13.81%-1.5M139.30%1.8M-126.64%-483.63K-1,158.81%-1.64M-21.36%1.72M-12,409.58%-1.32M422.39%753.04K
Effect of exchange rate changes 1,328.26%7.13K27.70%-1.44K-30.82%1.23K1,021.07%17.24K-1,101.94%-9.9K-99.19%499-103.68%-1.99K-80.97%1.78K511.23%1.54K36.12%-824
End cash Position -9.00%1.51M-9.00%1.51M24.69%4.12M24.76%1.97M19.24%3.45M-22.55%1.66M-22.55%1.66M48.78%3.3M8,167.45%1.58M9,551.25%2.89M
Free cash flow -21.24%-7.07M-11.44%-1.83M-24.11%-2.13M-13.88%-1.5M-39.35%-1.6M-25.12%-5.83M-1,159.55%-1.64M54.51%-1.72M-297.68%-1.32M-176.52%-1.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More